Stada’s ViruProtect Could Prevent COVID Infection, In Vitro Study Shows
Executive Summary
A recent in vitro study shows that Enzymatica's ColdZyme throat spray – the basis for Stada's ViruProtect in Belgium and Austria – could offer a protective barrier against harmful viruses such as SARS-CoV-2.